Mycoses: all 260 studies
Page 3 of 3. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetic Study of Posaconazole Boosted FosamprenavirCompletedNCT00817765Phase 1
- A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal InfectionsCompletedNCT00794703Phase 3
- TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.CompletedNCT00740389Phase 1
- Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of MycosesCompletedNCT00722189
- Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN)WithdrawnNCT00704951
- Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis PatientsStatus unknownNCT00697944Phase 4
- Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)Approved for marketingNCT00686621
- Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean PopulationsStatus unknownNCT00673348
- A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell TransplantCompletedNCT00606268Phase 1
- Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)CompletedNCT00548080Phase 3
- Fluconazole Pharmacokinetics in InfantsCompletedNCT00514358
- Prophylaxis of Fungal Invasive Infections in LeukemiaCompletedNCT00501098Phase 2
- Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT RecipientsWithdrawnNCT00430469Phase 1/2
- ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic LeukemiaTerminatedNCT00386997Phase 4
- A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED)CompletedNCT00379964Phase 3
- An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot StudyTerminatedNCT00371605
- A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of PhototoxicityCompletedNCT00353158Phase 1
- New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis PneumoniaCompletedNCT00342589
- Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell TransplantationCompletedNCT00336531Phase 4
- Prophylaxis With Caspofungin in High-Risk Liver TransplantationStatus unknownNCT00333645Phase 2
- PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00326157Phase 2
- Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)CompletedNCT00292071Phase 2
- Inhalation of Liposomal Amphotericin B to Prevent Invasive AspergillosisCompletedNCT00263315Phase 2/3
- Invasive Fungal Infections Surveillance InitiativeCompletedNCT00177944
- Voriconazole as Prophylaxis for Liver Transplant RecipientsCompletedNCT00177788
- Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095TerminatedNCT00177749Phase 4
- Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome StudyCompletedNCT00177710Phase 3
- Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)CompletedNCT00177684Phase 3
- A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell TransplantationCompletedNCT00148148Phase 2
- Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance SpectroscopyCompletedNCT00136968Phase 1
- Early Diagnosis of Candidiasis in Premature InfantsCompletedNCT00109525
- Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care UnitsCompletedNCT00099775Phase 3
- Caspofungin Study for Fungal Infections in Adults in Critical Care SettingsTerminatedNCT00095316Phase 3
- Anidulafungin Versus Fluconazole in the Treatment of CandidemiaCompletedNCT00058682Phase 3
- Daptomycin for the Treatment of Infections Due to Gram-Positive BacteriaTerminatedNCT00055198Phase 3
- Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)CompletedNCT00044486Phase 3
- PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)CompletedNCT00034671Phase 2
- Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)CompletedNCT00034658Phase 3
- Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host DiseaseCompletedNCT00034645Phase 3
- Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)CompletedNCT00034632Phase 3
- Posaconazole to Treat Invasive Fungal InfectionsCompletedNCT00033982Phase 3
- Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant RecipientsCompletedNCT00026767
- Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal InfectionsCompletedNCT00015665Phase 3
- Voriconazole to Prevent Systemic Fungal Infections in ChildrenCompletedNCT00005912Phase 1
- Phase II Study of Fluconazole for Lymphocutaneous and Visceral SporotrichosisCompletedNCT00004938Phase 2
- Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and SporotrichosisCompletedNCT00004811Phase 1/2
- Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and SporotrichosisCompletedNCT00004808Phase 2
- Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk GroupsCompletedNCT00004781
- A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are CommonCompletedNCT00002325Not applicable
- A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal InfectionsCompletedNCT00002277Phase 3
- A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected PatientsCompletedNCT00002122Phase 3
- Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal TherapyCompletedNCT00002038Not applicable
- Voriconazole to Treat Fungal InfectionsCompletedNCT00001940Phase 3
- Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant PatientsCompletedNCT00001937Phase 3
- An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsCompletedNCT00001810Phase 3
- Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and NeutropeniaCompletedNCT00001790Phase 1
- An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsCompletedNCT00001757Phase 3
- Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous DiseaseCompletedNCT00001280Phase 2
- Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine MetabolitesCompletedNCT00000826Phase 1
- Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)CompletedNCT00000676Phase 3